Skip to main navigation
  • Our Science
  • AT-527
  • COVID-19
  • About Atea
    • About Us
    • Pipelines & Programs
    • Leadership
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
      • Publications
    • Financials
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
    • Stock Info
      • Stock Quote & Chart
      • Historical Price Look up
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Shareholder Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
      • RSS Feeds
  • Careers
  • Contact
The tip of a pipette pointing towards droplets suspended in a green solution.

Investor Relations

Board of Directors

Breadcrumb

  1. Investors
  2. Board of Directors

Board of Directors

Jean-Pierre Sommadossi, PhD
Chairman & CEO, Atea Pharmaceuticals
Read More
Jerome Adams, M.D., M.P.H.
Former Surgeon General of the United States
Read More
Member of the Nominating and Corporate Governance Committee
Chair of the Strategy and Public Policy Committee
Franklin Berger
Founding & Managing Director, FMB Research
Read More
Member of the Audit Committee
Chair of the Compensation Committee
Barbara Duncan
Former CFO, Intercept Pharmaceuticals
Read More
Chair of the Audit Committee
Member of the Nominating and Corporate Governance Committee
Bruno Lucidi
Life Sciences Expert, Wallonia Trade and Foreign Investment Agency (AWEX)
Read More
Member of the Compensation Committee
Member of the Audit Committee
Polly A. Murphy, D.V.M., Ph.D.
Chief Business Officer, Urogen Pharma
Read More
Chair of the Nominating and Corporate Governance Committee
Member of the Strategy and Public Policy Committee
Bruce Polsky, M.D
Professor and Chairman, Department of Medicine, NYU Langone Hospital – Long Island; Assoc. Dean, Faculty, NYU Long Island School of Medicine
Read More
Member of the Compensation Committee
Member of the Strategy and Public Policy Committee
Investor FAQs
RSS Feeds
Email Alerts
Contact IR

Atea is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment.

  • Atea Pharmaceuticals, Inc.
  • 225 Franklin Street
  • Suite 2100
  • Boston, MA 02110
  • (857) 284-8891

Copyright © 2023 By Atea Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy | Terms of Use